Success Metrics

Clinical Success Rate

85.7%

Based on 6 completed trials

Completion Rate

86%(6/7)

Active Trials

0(0%)

Results Posted

33%(2 trials)

Terminated

1(14%)

Phase Distribution

Ph phase_2

29%

Ph phase_1

14%

Ph phase_3

14%

Ph phase_4

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

1(16.7%)

Phase 2Efficacy & side effects

2(33.3%)

Phase 3Large-scale testing

1(16.7%)

Phase 4Post-market surveillance

2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Terminated(1)

Detailed Status

Completed6

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

85.7%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (16.7%)

Phase 22 (33.3%)

Phase 31 (16.7%)

Phase 42 (33.3%)

Trials by Status

terminated114%

completed686%

Recent Activity

0 active trials

Showing 5 of 7

completedphase_1

Electrophysiological Effects of Potential QT Prolonging Drugs

NCT05716854

completed

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

NCT02600741

completedphase_4

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

NCT02307396

terminatedphase_3

Pharmacovigilance in Gerontopsychiatric Patients

NCT02374567

completedphase_2

Efficacy of Pimozide Augmentation for Clozapine Partial Response

NCT00374244

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT05716854Phase 1

Electrophysiological Effects of Potential QT Prolonging Drugs

Completed

NCT02600741

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

Completed

NCT02307396Phase 4

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

Completed

NCT02374567Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

Terminated

NCT00374244Phase 2

Efficacy of Pimozide Augmentation for Clozapine Partial Response

Completed

NCT00158223Phase 4

Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia

Completed

NCT00004652Phase 2

Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7